13FMonte Rosa Therapeutics Inc (GLUE)
4 tracked managers currently hold GLUE on their latest filing. Change is versus that manager’s previous filing. Reported as of quarter end, filed up to ~45 days later, not live positions.
Sort: Size Weight change
Sorted by reported value on the latest filing.
| Manager | Period | Change | Value | Weight | Prev weight | Shares | Δ shares |
|---|---|---|---|---|---|---|---|
| Duquesne Family Office LLC | Q2 2026 | NEW | $7.2M | 0.2 % | — | 297,600 | NEW |
| D. E. Shaw & Co., Inc. | Q2 2026 | ADD | $4.2M | 0.0 % | 0.0 % | 172,053 | +105,726 |
| CITADEL ADVISORS LLC | Q2 2026 | TRIM | $4.0M | 0.0 % | 0.0 % | 163,571 | -90,947 |
| TWO SIGMA INVESTMENTS, LP | Q2 2026 | ADD | $3.4M | 0.0 % | 0.0 % | 140,923 | +121,623 |